Statin‐associated autoimmune myopathy and anti‐HMGCR autoantibodies
- 30 August 2013
- journal article
- review article
- Published by Wiley in Muscle & Nerve
- Vol. 48 (4) , 477-483
Abstract
Statins are among the most commonly prescribed medications that significantly reduce cardiovascular risk in selected individuals. However, these drugs can also be associated with muscle symptoms ranging from mild myalgias to severe rhabdomyolysis. Although statin myotoxicity is usually self‐limited, in some instances statin‐exposed subjects can develop an autoimmune myopathy typically characterized by progressive weakness, muscle enzyme elevations, a necrotizing myopathy on muscle biopsy, and autoantibodies that recognize 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR), the pharmacologic target of statins. These antibodies are also found in some autoimmune myopathy patients without statin exposure. Importantly, anti‐HMGCR antibodies are not found in the vast majority of statin‐exposed subjects without autoimmune myopathy, including those with self‐limited statin intolerance. Thus, testing for these antibodies may help differentiate those with self‐limited statin myopathy who recover after statin discontinuation from those with a progressive statin‐associated autoimmune myopathy who typically require immunosuppressive therapy.Muscle Nerve48: 477–483, 2013Keywords
Funding Information
- National Institutes of Health (K08-AR-054783)
This publication has 48 references indexed in Scilit:
- Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysisBMC Musculoskeletal Disorders, 2012
- Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effectsArthritis Care & Research, 2011
- Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathyArthritis & Rheumatism, 2010
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- A novel autoantibody recognizing 200‐kd and 100‐kd proteins is associated with an immune‐mediated necrotizing myopathyArthritis & Rheumatism, 2010
- Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controlsAnnals of the Rheumatic Diseases, 2010
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Statin Induced Myopathy and Myalgia: Time Trend Analysis and Comparison of Risk Associated with Statin Class from 1991–2006PLOS ONE, 2008
- Prevalence of Musculoskeletal Pain and Statin UseJournal of General Internal Medicine, 2008
- Genetic determinants of statin intoleranceLipids in Health and Disease, 2007